Health Services Research
Latest posts by Health Services Research (see all)
- Young Adult Dependent Coverage: Were the State Reforms Effective? A Critique and a Response - May. 21, 2015
- Drawing Plausible Inferences about the Impact of State Dependent Coverage Expansions - May. 21, 2015
- Estimating True Resource Costs of Outpatient Care for Medicare Beneficiaries: Standardized… - May. 19, 2015
- Medicaid Expansions and Crowd-Out: Evidence from HIFA Premium Assistance Programs - May. 18, 2015
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: